Inventor
SEMPLE GRAEME
US30 patents
⚠️ This page may combine multiple inventors who share the name “SEMPLE GRAEME”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
16 patentsUS7132426B2Nov 7, 2006
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC56 citations95
US7838525B2Nov 23, 2010
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC39 citations92
US7470699B2Dec 30, 2008
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC41 citations92
US7625906B2Dec 1, 2009
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC11 citations83
US10272094B2Apr 30, 2019
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC1 citations73
US10392390B2Aug 27, 2019
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC6 citations72
US10836764B2Nov 17, 2020
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC2 citations71
US9676758B2Jun 13, 2017
1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC3 citations66
US11395824B2Jul 26, 2022
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC0 citations62
US10624900B2Apr 21, 2020
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC1 citations62
US11608339B2Mar 21, 2023
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC0 citations60
US7241792B2Jul 10, 2007
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
ARENA PHARM INC4 citations60
US12559462B2Feb 24, 2026
Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations52
US9365511B2Jun 14, 2016
Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders
ARENA PHARM INC0 citations51
US7612106B2Nov 3, 2009
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
ARENA PHARM INC1 citations49
US7803837B2Sep 28, 2010
4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
ARENA PHARM INC0 citations41
FERRING BV
5 patentsUS6214798B1Apr 10, 2001
GnRH antagonists being modified in positions 5 and 6
FERRING BV62 citations96
US5925730AJul 20, 1999
GnRH antagonists
FERRING BV60 citations96
US5821230AOct 13, 1998
GnRH antagonist decapeptides
FERRING BV57 citations96
US5962451AOct 5, 1999
Benzodiazepin derivatives useful as CCK-receptor antagonists
FERRING BV8 citations71
US7176195B2Feb 13, 2007
Fused azepine derivatives and their use as antidiuretic agents
FERRING BV8 citations63
JONES ROBERT M
4 patentsUS8410119B2Apr 2, 2013
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M8 citations82
US8293751B2Oct 23, 2012
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JONES ROBERT M8 citations78
US8546429B2Oct 1, 2013
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M0 citations51
US8933083B2Jan 13, 2015
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JONES ROBERT M0 citations46